Vital KSK Holdings () is engaged in the wholesaling and retailing of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments.The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners.The Other segment includes the retailing of pharmaceutical products, wholesaling of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies.All the business activity of the group is primarily conducted in Japan though the company distributes product within Korea overseas markets.Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.Three key data points gauge Vital KSK or any dividend paying firm.The key three are:(1) Price(2) Dividends(3) ReturnsThose three keys also best tell whether any company has made, is making, and will make money.
VKSKF PriceVital KSK’s share price was unchanged in the past year holding at $7.02 as of Thursday’s market close.In the past 3 years the company’s share price has rarely been less than $5.95 nor more than $7.02.If shares trade in the range of $6.00 to $9.00 this next year, the recent $7.02 share price might grow to $8.00. Of course, VKSKF share price could also drop about the same $0.98 estimated amount, or more.My $0.98 price upside estimate is based on the average of the company’s annual price momentum over the past two years
VKSKF Dividend
Vital KSK has paid semi-annual dividends since December 2020. The company’s most recent SA dividend of $0.14 was declared May 13th for shareholders of record September 27th, and the payout is due December 3rd.The estimated annual dividend of $0.14 yields 2.06% as of Thursday’s closing price. A second semi-annual dividend payment was not declared.
VKSKF ReturnsPutting it all together, a $1.12 estimated annual gross gain per share shows up by adding Vital KSK’s annual $0.14 dividend to the estimated price upside of $0.98, totaling that $1.12 gross gain.A little over $1000 buys 142 shares at Thursday’s $7.02 share price.A $10 broker fee (if charged), collected half at purchase and half at sale, might take about $0.07 per share out of the $1.12 gross-gain to give us a net gain of $1.05 X 142 shares = $149.10 for about a 15% estimated net gain for the year.Furthermore, the $20.60 annual estimated dividend from $1k invested is near 3 times more than the $7.02 single share price. By these numbers, VKSKF could be a good dividend dog.Therefore, you might choose to pounce on Vital KSK. It is a 15 year-old dividend paying Japanese pharmaceutical wholesale and retail company with a 4-year dividend record.The exact track of Vital KSKs future price and dividend will entirely be determined by market action and company finances.Remember the best measure of stock value is through direct ownership of shares.More By This Author:
Current Report: Vital KSK Holdings
